Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the tolerability, safety, and efficacy of Liposomal
Curcumin (LC) in combination with radiotherapy (RT) and Temozolomide (TMZ) in patients with
newly diagnosed High-Grade Gliomas (HGG).